NCT02612064 - The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity | Biotech Hunter

Enrollment

488

Participants

Timeline

Start Date

November 1, 2015

Primary Completion Date

June 3, 2016

Study Completion Date

June 3, 2016

Conditions

Dentin Sensitivity

Interventions

DEVICE

Stannous Fluoride dentifice

Experimental dentifrice containing 0.454% w/w stannous fluoride (1100ppm)

OTHER

Sodium Monofluorophosphate dentifrice

Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)

Trial Locations (2)

GSK Investigational Site, Ellesmere Port

GSK Investigational Site, Metropolitan Borough of Wirral